Helpdesk

Sales contact

Uncategorized

2023 Gender Equality Index

In accordance with the provisions of the "Professional Future" law of September 5, 2018, Kayentis has established its Gender Equality Index. What is the professional equality index? The index evaluates...

Infographic

Televisits for more engaging clinical trials

Televisit

If it is important to enable televisits for DCT trials, embedding the feature directly into the eCOA app brings multiple...

Webinar

We spoke at DMB on “The shift to ePRO collection at home: Strategies to preserve data quality and re-think compliance”

Date: November 22 Time: 11:15AM CET Location: Paris, France Presentation in French See the full DMB Annual Conference program &...

We co-organized the France Biotech Symposium on Decentralized Clinical Trials in Paris!

Date: October 18Location: PariSanté Campus in ParisOBJECTIVES: Define decentralized clinical trials, provide an update on their development and implementation in...

Webinar

“Get ready for fully remote eCOA in your next DCT trial” webinar

Are you ready for fully remote eCOA in your next DCT trial? Learn how to build a better plan for...

Infographic

Customizing eCOA questionnaire design to improve the pediatric experience

Pediatric

Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to customize questionnaire design with illustrations...

Infographic

How Kayentis reduces the CO2 emissions of your eCOA projects with its carbon neutral program

CSR

In 2020, we implemented a carbon neutral program for all our clinical trials. Our goal? To reduce project CO2 emissions...

Infographic

Patients as partners in clinical trials – Survey results

Patients insights

We collaborate with patients to characterize their clinical trials expectations and better understand their readiness for remote clinical trials.This 11-question...

What can eDiary bring to your study?

During a clinical trial, in particular for late phase trials, it becomes increasingly important to be able to collect a...

Infographic

The benefits of the eICF in patient engagement

The patient’s role in clinical trials, as well as the general image of patient care, is evolving. The patient is...

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA